Medical Research Council Dyspnoea Scale
Also known as: MRC, MRC Dyspnea, Modified Borg
The MRC Dyspnoea Scale is a simple 5-grade ordinal classification of dyspnea severity based on the exertional threshold at which breathlessness limits activity. Developed by the UK Medical Research Council (MRC) in 1959, it remains one of the most widely used dyspnea assessments globally due to its brevity, ease of administration, and strong prognostic correlation in chronic obstructive pulmonary disease and other chronic respiratory diseases. The scale is used in clinical practice, epidemiological surveys, and longitudinal disease monitoring to grade symptom severity and guide treatment intensity.
Key highlights
- Exceptional simplicity: Five grades require <2 minutes to rate; no special equipment or training needed
- Strong prognostic value: MRC grade correlates with COPD mortality, exacerbation risk, and healthcare utilization; Grade 3–4 patients have markedly elevated mortality
- Functional anchoring: Grades describe real-world exertional activities (stairs, walking, self-care), making the scale intuitive for patients across education levels
- Global availability: Single grading system, easy translation, and widespread adoption across >100 countries enable international comparison and research
Intuition
This section is available to Pro members. Upgrade to Pro
How it works
This section is available to Pro members. Upgrade to Pro
When to use it
The MRC Dyspnoea Scale is indicated for any patient with dyspnea attributable to chronic pulmonary or cardiac disease (COPD, ILD, asthma, pulmonary hypertension, chronic heart failure). It is particularly useful in primary care and general medical settings where time is limited and a rapid dyspnea assessment is needed. The MRC scale is ideal for epidemiological surveys, population screening, and longitudinal disease registries. It is less useful for acute dyspnea assessment (which may fluctuate over hours) or for quantifying dyspnea intensity during exercise (use the Borg scale instead).
Strengths & limitations
- Exceptional simplicity: Five grades require <2 minutes to rate; no special equipment or training needed
- Strong prognostic value: MRC grade correlates with COPD mortality, exacerbation risk, and healthcare utilization; Grade 3–4 patients have markedly elevated mortality
- Functional anchoring: Grades describe real-world exertional activities (stairs, walking, self-care), making the scale intuitive for patients across education levels
- Global availability: Single grading system, easy translation, and widespread adoption across >100 countries enable international comparison and research
- Ordinal (not continuous) scale: Only five possible grades limit granular discrimination; adjacent grades may represent substantial actual symptom differences
- Exertional context dependency: Patients with sedentary lifestyle may underreport dyspnea if they avoid triggering activities; objective activity monitoring needed for context
- Limited psychometric data: Fewer formal reliability/validity studies compared to multi-item questionnaires; reproducibility varies across populations
- No domain specificity: Single dyspnea item; does not capture cough, sputum, sleep disruption, or emotional impacts
Common pitfalls
This section is available to Pro members. Upgrade to Pro
Applications
This section is available to Pro members. Upgrade to Pro
Frequently asked
How does MRC Dyspnoea differ from the Borg Scale?
MRC is ordinal (5 grades) and functional (linked to exertional activities); administered at rest, reflects typical daily limitation. Borg is continuous (0–10) and intensity-focused; administered during or immediately after exercise, quantifies real-time breathlessness sensation. Use MRC for routine clinical assessment; use Borg for exercise testing.
A patient improves from Grade 4 to Grade 3; is this clinically meaningful?
Yes, a one-grade improvement is considered clinically meaningful. Grade 3 to 4 represents a substantial difference: Grade 4 patient cannot walk far on level ground, while Grade 3 patient can walk but at reduced pace. One-grade shifts should trigger clinical discussion about therapy response.
Can MRC be used for asthma, or only COPD?
MRC is valid for any chronic dyspnea etiology: COPD, ILD, asthma, pulmonary hypertension, heart failure. However, asthma dyspnea may be intermittent, requiring clarification: assess dyspnea when asthma is uncontrolled. In controlled asthma, MRC grade may be 1.
My patient says Grade 3, but my clinical impression is Grade 2. How should I resolve this?
Discordance between patient report and clinician impression suggests exploring context: Is the patient avoiding exertion? Have they recently worsened? Objective testing (spirometry, oximetry during exertion) can clarify. Document both patient and clinician impressions; patient perception of limitation is clinically important even if objective severity differs.
Sources
- 1.Van Swieten, J. C., Koudstaal, P. J., Visser, M. C., Schouten, H. J., & van Gijn, J. (1988). Interobserver agreement for the assessment of handicap in stroke patients. Stroke, 19(5), 604-607.
- 2.Bestall, J. C., Paul, E. A., Garrod, R., Garnham, R., Jones, P. W., & Wedzicha, J. A. (1999). Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax, 54(7), 581-586.
You have read it. What now?
Cite this page
ScholarGate. (2026, June 3). MRC Dyspnoea. ScholarGate. https://scholargate.app/pulmonology/mrc-dyspnoea-scale